Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Tychy – page 37

1 211 clinical trials in Tychy, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Tychy at a glance
1 211
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

1 211 trials in Tychy

Open in trial search

Efficacy and Safety of Atumelnant, Hydrocortisone and Prednisone in Adults with ACTH‑Dependent Cushing’s Syndrome: A Phase 2/3 Dose‑Finding Study

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Atumelnant
  • Sponsor:Crinetics Pharmaceuticals Inc.

Colitis ulcerative

Not yet recruiting

Phase 2b Study of ATH-063 in Adults with Biologic‑Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis

Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:ATH-063 hydrochloride
  • Sponsor:Athos Therapeutics Inc.

Type 2 diabetes mellitus+2

Not yet recruiting

Efficacy and Safety of Olatorepatide in Adults with Overweight or Obesity and Type 2 Diabetes

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Olatorepatide
  • Sponsor:Regeneron Pharmaceuticals Inc.

Dermatitis atopic

Not yet recruiting

A Phase 2b Study Evaluating the Efficacy and Safety of ENV-294 in Adults with Moderate-to-Severe Atopic Dermatitis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:ENV-294
  • Sponsor:Enveda Therapeutics Inc.

Type 2 diabetes mellitus

Not yet recruiting

Study of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S

Type 2 diabetes mellitus

Not yet recruiting

Efficacy and Safety of Alogliptin Plus Empagliflozin Compared with Alogliptin Alone or Empagliflozin Alone in Adults with Type 2 Diabetes on Metformin

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Alogliptin
  • Sponsor:Tecnimede-Sociedade Tecnico-Medicinal S.A.

Ocular myasthenia

Not yet recruiting

Phase 3 Open‑Label Extension Study of Long‑Term Safety and Efficacy of Rozanolixizumab in Adults with Ocular Myasthenia Gravis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rozanolixizumab
  • Sponsor:UCB Biopharma

Plasma cell myeloma

Not yet recruiting

Dapagliflozin for Primary Cardioprotection in Newly Diagnosed Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation – A Randomized Phase 2 Study

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Instytut Hematologii I Transfuzjologii

Major depression

Not yet recruiting

Evaluation of Trazodone Hydrochloride for Improving Emotional Blunting in Patients with Major Depressive Disorder

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Trazodone hydrochloride
  • Sponsor:Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesc O A.C.R.A.F. S.p.A.

Acne

Not yet recruiting

Safety and Efficacy Study of the Acne mRNA vaccine (mrt1800, mrt1801, mrt1802) in Adults 18‑45 Years with Moderate to Severe Acne

Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:MRT1800
  • Sponsor:Sanofi Pasteur Inc.

Aortic valve stenosis

Not yet recruiting

A Phase 2b/3 Randomized Double‑Blind Study of Ataciguat to Slow Disease Progression in Adults with Moderate Calcific Aortic Valve Stenosis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ataciguat
  • Sponsor:Kardigan Inc.

Asthma

Not yet recruiting

Asthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Beclometasone Dipropionate
  • Sponsor:Chiesi Farmaceutici S.p.A.

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Tychy

What the registry says about research in the country

01 Gastrointestinal Research

Comprehensive studies focusing on inflammatory bowel diseases, including multiple trials investigating new treatments for Crohn's Disease and Ulcerative Colitis. Research aims at evaluating novel therapeutic approaches for both moderate and severe cases.

  • Crohn's Disease Management
  • Ulcerative Colitis Treatments
  • Eosinophilic Esophagitis Studies

Clinical investigations are examining both established and experimental medications to improve patient outcomes and quality of life.

02 Cardiovascular Studies

Extensive research into heart conditions and related disorders, with particular focus on heart failure, myocardial infarction, and hypertension management. Studies evaluate both new medications and innovative treatment approaches.

  • Heart Failure Therapies
  • Post-Heart Attack Treatment
  • Blood Pressure Management

Trials are investigating both preventive measures and therapeutic interventions for various cardiovascular conditions.

03 Respiratory Research

Innovative studies focusing on respiratory infections and preventive treatments, particularly in vulnerable populations. Research includes evaluation of new preventive therapies for RSV in infants.

  • RSV Prevention
  • Respiratory Infection Management
  • Pediatric Respiratory Care

Clinical trials aim to develop effective preventive measures and treatments for respiratory conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.